• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, January 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New study may have the reason why heart medication gives muscle pain

Bioengineer by Bioengineer
October 15, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: McMaster University


Hamilton, ON (October 15, 2019) – A study from McMaster University has found a potential mechanism explaining why some people who take drugs to lower their cholesterol develop sore, aching muscles.

The use of statin drugs to significantly lower cholesterol, and ultimately reduce the risk of cardiovascular disease, has become widespread and large-scale studies suggest that nearly half of Americans and a quarter of Canadians are receiving or are eligible for statin treatment.

Unfortunately, a very common side-effect of statin use is the development of muscle pain. In fact, that muscle pain is the primary reason for why people stop taking their statin medication without their physician’s permission.

Understanding why statins cause muscle pain and how this could be treated could remove a significant obstacle for healthcare professionals to effectively manage a patient’s cholesterol and lower their cardiovascular disease risk

The McMaster research team found muscle cells treated with statins released the amino acid called glutamate at much higher levels than muscle cells that were untreated. As glutamate is a potent activator of muscle pain receptors, this release was proposed to trigger the sensation of muscle pain.

Thomas Hawke, senior author of the study and a professor in pathology and molecular medicine at McMaster University said: “We found that statins were able to enter the muscle cells and cause oxidative stress. This resulted in the muscle trying to increase its production of antioxidants to combat this stress. The side-effect of this antioxidant production was the release of glutamate out of the muscle cells.”

Irena Rebalka, first author of the study and a research associate in the Hawke Lab added: “We found that administering some well-known antioxidants, such as Vitamin E, were successful in helping reduce glutamate release. We are now expanding our studies to determine further compounds which could be used in conjunction with a person’s statin prescription to reduce the burden of muscle pain resulting from this drug.”

###

The paper was published today in the American Journal of Physiology- Cell Physiology. The study may be found at https://bit.ly/33BeV8S

The study was funded in by the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation.

Media contact:

Veronica McGuire, Media Relations, Faculty of Health Sciences, McMaster University [email protected] 905-525-9140, ext. 22169

Media Contact
Veronica McGuire
[email protected]
905-525-9140 x22169

Tags: CardiologyMedicine/HealthPhysiology
Share12Tweet8Share2ShareShareShare2

Related Posts

Resilience Factors Supporting NICU Parents’ Emotional Well-being

January 13, 2026

Prior Hypoglycemia Boosts Somatostatin, Weakens Glucagon

January 13, 2026

Osimertinib ± Savolitinib in MET-EGFR NSCLC Trial

January 13, 2026

Acute Mesenteric Ischemia in Elderly: Clinical Insights

January 13, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    154 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    147 shares
    Share 59 Tweet 37
  • Robotic Ureteral Reconstruction: A Novel Approach

    72 shares
    Share 29 Tweet 18
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    52 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Battery-Electric Cars to Be Affordable Across Africa Before 2040

Resilience Factors Supporting NICU Parents’ Emotional Well-being

Prior Hypoglycemia Boosts Somatostatin, Weakens Glucagon

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.